Arena Investors’s Rapid Micro Biosystems RPID Stock Holding History

Arena Investors’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,965	Closed	-$2.22K	–	86
2022 Q4	$2.22K	Sell	1,965 -188,082	-99%	-$455K	﹤0.01%	86
2022 Q3	$614K	Sell	190,047 -44,953	-19%	-$174K	0.29%	63
2022 Q2	$1.01M	Buy	+235,000	New	+$1.09M	0.45%	49

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

RMC

Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Arena Investors's RPID Position: Q1 2023 in Review

Arena Investors sold out of Rapid Micro Biosystems (RPID) in Q1 2023, closing a stake of 1,965 shares — an estimated $2.22K sold.

Arena Investors first reported a position in RPID in Q2 2022 and held it in 3 quarters. The position peaked at $1.01M in Q2 2022. 31 funds tracked by Wall St. Rank hold RPID as of Q1 2023.

Arena Investors reported no remaining Rapid Micro Biosystems position as of Q1 2023 after selling out during the quarter.
Arena Investors sold 1,965 Rapid Micro Biosystems shares in Q1 2023, an estimated $2.22K.
Arena Investors first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 3 quarters.
Arena Investors's Rapid Micro Biosystems position peaked at $1.01M in Q2 2022.
31 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2023.

Based on Arena Investors's 13F filing for Q1 2023, filed 15 May 2023.